BriaCell Therapeutics Corp (BCTXW) — Capital Reinvestment Ratio
Latest as of October 2012:
116.81x
BriaCell Therapeutics Corp (BCTXW) has a Capital Reinvestment Ratio of 116.81x as of October 2012, meaning it reinvests 117% of its operating cash flow ($3.96K) in capital expenditures ($462.21K). Check BriaCell Therapeutics Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
116.81x
Capex / Operating Cash Flow
Operating Cash Flow
$3.96K
USD
Capital Expenditures
$462.21K
USD
Data as of
Oct 2012
Most recent filing
Annual Capital Reinvestment Ratio for BriaCell Therapeutics Corp (None–None)
Year-by-year Capital Reinvestment Ratio for BriaCell Therapeutics Corp from None to None. See BriaCell Therapeutics Corp (BCTXW) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow